TN2013000515A1 - Notch pathway signaling inhibitor compound - Google Patents

Notch pathway signaling inhibitor compound

Info

Publication number
TN2013000515A1
TN2013000515A1 TNP2013000515A TN2013000515A TN2013000515A1 TN 2013000515 A1 TN2013000515 A1 TN 2013000515A1 TN P2013000515 A TNP2013000515 A TN P2013000515A TN 2013000515 A TN2013000515 A TN 2013000515A TN 2013000515 A1 TN2013000515 A1 TN 2013000515A1
Authority
TN
Tunisia
Prior art keywords
signaling inhibitor
notch pathway
pathway signaling
inhibitor compound
compound
Prior art date
Application number
TNP2013000515A
Other languages
English (en)
Inventor
Philip Arthur Hipskind
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/047100 external-priority patent/WO2013016081A1/fr
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2013000515A1 publication Critical patent/TN2013000515A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNP2013000515A 2011-11-16 2013-12-12 Notch pathway signaling inhibitor compound TN2013000515A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161560486P 2011-11-16 2011-11-16
PCT/US2012/047100 WO2013016081A1 (fr) 2011-07-27 2012-07-18 Composé inhibiteur de la signalisation par la voie notch

Publications (1)

Publication Number Publication Date
TN2013000515A1 true TN2013000515A1 (en) 2015-03-30

Family

ID=54359619

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000515A TN2013000515A1 (en) 2011-11-16 2013-12-12 Notch pathway signaling inhibitor compound

Country Status (1)

Country Link
TN (1) TN2013000515A1 (fr)

Similar Documents

Publication Publication Date Title
JO3148B1 (ar) مركب مثبط لإشارات مسار notch
SA515360469B1 (ar) مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها
MX351892B (es) Combinaciones de compuestos inhibidores de akt y abiraterona y metodos de uso.
MX2015011245A (es) Un inhibidor de mdm2 derivado de acido benzoico para el tratamiento del cancer.
AU2012214029A8 (en) Rorgammat inhibitors
IN2014DN10670A (fr)
MD4659B1 (ro) Polimorf al inhibitorilor SYK
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
MX2011009796A (es) Inhibidores de la cinasa pi3.
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
MD4684B1 (ro) Formulări pe bază de imidazopirazine în calitate de inhibitori SYK
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
MX362879B (es) Usos novedosos.
PH12014502492A1 (en) Pyrazole compounds as sglt1 inhibitors
MX362896B (es) Cis-morfolinona y otros compuestos como inhibidores de mdm2 para el tratamiento del cáncer.
JO3145B1 (ar) مركبات مفيدة لتثبيط chk1
TN2013000515A1 (en) Notch pathway signaling inhibitor compound
UA110834C2 (uk) Сполука-інгібітор сигнального шляху notch
TN2014000077A1 (en) Pyridazinone compounds and their use as daao inhibitors
JOP20120346B1 (ar) مركبات لعلاج ومنع الإلتصاق، وتركيبات صيدلية متعلقة بالمركب وطرق لمنع وعلاج الإلتصاقات
TN2011000507A1 (en) Inhibitors of pi3 kinase and / or mtor